The Biden administration has announced the first 10 medications that will be subject to price negotiations under Medicare -- a key Democratic priority stemming from last year's Inflation Reduction Act. Larry Levitt, executive vice president for health policy at KFF, joined CBS News to discuss what the negotiations mean.
